Giuliani International Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for Giuliani International Limited.The latest application filed is for "analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation".

Company Profile

0.8.3

Giuliani International Limited -
Giuliani International Limited - Dublin IE
Giuliani International, Ltd. - Dublin IE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Analogous Compounds of 6-Thioguanosine Triphosphate, their use in Medical Fields and Processes for their Preparation App 20120094948 - Naccari; Giancarlo ; et al.	2012-04-19
Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease Grant 8,153,693 - Baroni , et al. April 10, 2	2012-04-10
Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field Grant 8,153,841 - Naccari , et al. April 10, 2	2012-04-10
Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field Grant 8,138,357 - Naccari , et al. March 20, 2	2012-03-20
Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation Grant 8,114,986 - Naccari , et al. February 14, 2	2012-02-14
Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field Grant 8,106,182 - Monteleone January 31, 2	2012-01-31
Antisense Compositions And Methods Of Making And Using Same App 20120015033 - Baroni; Sergio ; et al.	2012-01-19
Combination of catechin and quercetin for pharmaceutical or dietary use Grant 7,956,040 - Trimboli , et al. June 7, 2	2011-06-07
Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field Grant 7,807,818 - Monteleone October 5, 2	2010-10-05
SMAD7 inhibitors for the treatment of CNS diseases Grant 7,700,572 - Steinbrecher , et al. April 20, 2	2010-04-20
Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field App 20090118357 - Naccari; Giancarlo ; et al.	2009-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.